BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29139591)

  • 21. Radiologic-pathologic correlation of ductal carcinoma in situ.
    Yamada T; Mori N; Watanabe M; Kimijima I; Okumoto T; Seiji K; Takahashi S
    Radiographics; 2010 Sep; 30(5):1183-98. PubMed ID: 20833844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.
    Aminololama-Shakeri S; Abbey CK; Gazi P; Prionas ND; Nosratieh A; Li CS; Boone JM; Lindfors KK
    Eur J Radiol; 2016 Jan; 85(1):297-303. PubMed ID: 26520874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent.
    Santamaría G; Velasco M; Farrús B; Zanón G; Fernández PL
    Breast; 2008 Apr; 17(2):186-94. PubMed ID: 17964786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of breast magnetic resonance imaging in the diagnosis of ductal carcinoma in situ].
    Nadrljanski M; Milosević Z; Plesinac-Karapandzić V; Goldner B
    Srp Arh Celok Lek; 2013; 141(5-6):402-8. PubMed ID: 23858817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
    Grimm LJ; Ghate SV; Hwang ES; Soo MS
    Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
    Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
    Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project.
    Evans A; Clements K; Maxwell A; Bishop H; Hanby A; Lawrence G; Pinder SE;
    Clin Radiol; 2010 Mar; 65(3):181-4. PubMed ID: 20152272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammographically non-calcified ductal carcinoma in situ: sonographic features with pathological correlation in 35 patients.
    Mesurolle B; El-Khoury M; Khetani K; Abdullah N; Joseph L; Kao E
    Clin Radiol; 2009 Jun; 64(6):628-36. PubMed ID: 19414087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological characteristics of breast ductal carcinoma in situ and association with imaging findings.
    Tang X; Yamashita T; Hara M; Kumaki N; Tokuda Y; Masuda S
    Breast Cancer; 2016 May; 23(3):491-8. PubMed ID: 25644245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
    Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
    J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. US appearance of ductal carcinoma in situ.
    Wang LC; Sullivan M; Du H; Feldman MI; Mendelson EB
    Radiographics; 2013; 33(1):213-28. PubMed ID: 23322838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
    Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
    Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinics in diagnostic imaging (180). Ductal carcinoma in situ (DCIS).
    Tan EJ; Moey T; Madhukumar P; Leong LC
    Singapore Med J; 2017 Oct; 58(10):585-592. PubMed ID: 29119195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ductal carcinoma in situ of the breasts: review of MR imaging features.
    Greenwood HI; Heller SL; Kim S; Sigmund EE; Shaylor SD; Moy L
    Radiographics; 2013 Oct; 33(6):1569-88. PubMed ID: 24108552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of 3 T versus 1.5 T breast MRI for pre-operative assessment of extent of disease in newly diagnosed DCIS.
    Rahbar H; DeMartini WB; Lee AY; Partridge SC; Peacock S; Lehman CD
    Eur J Radiol; 2015 Apr; 84(4):611-6. PubMed ID: 25604909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-calcified ductal carcinoma in situ: ultrasound and mammographic findings correlated with histological findings.
    Cho KR; Seo BK; Kim CH; Whang KW; Kim YH; Kim BH; Woo OH; Lee YH; Chung KB
    Yonsei Med J; 2008 Feb; 49(1):103-10. PubMed ID: 18306476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic-radiologic correlations in screen-detected ductal carcinoma in situ of the breast: findings of the Singapore breast screening project.
    Tan PH; Ho JT; Ng EH; Chiang GS; Low SC; Ng FC; Bay BH
    Int J Cancer; 2000 Aug; 90(4):231-6. PubMed ID: 10993963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of breast MRI for ductal carcinoma in situ appearing as microcalcifications only on mammography.
    Rinaldi P; Buccheri C; Giuliani M; Bufi E; Romani M; Patrolecco F; Belli P; Bonomo L
    Clin Imaging; 2016; 40(6):1207-1212. PubMed ID: 27618803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.